Speechmatics

Product overview

Speechmatics is a Cambridge-based company that provides speech-to-text technology through APIs used by businesses in media, contact centers, healthcare, legal, and finance. The platform supports over 55 languages for transcription and 69 language pairs for translation, with both real-time and batch processing modes. The company's models are trained on millions of hours of unlabelled voice data, which allows them to handle diverse accents, dialects, and noisy environments without bias toward specific speaker demographics. Founded in 2006 by Dr. Tony Robinson, who pioneered the application of neural networks to speech recognition at Cambridge University, the company was originally called Cantab Research. It has raised over $72 million in funding, including a $62 million Series B led by Susquehanna Growth Equity in 2022. Other investors include AlbionVC, IQ Capital, and Amadeus Capital Partners. Speechmatics differentiates itself through flexible deployment: customers can run the engine in the cloud, on-premise, or on-device depending on privacy requirements. The company says its data is not logged by default. Clients include Deloitte, Veritone, Vonage, and government agencies. The company was named to the Financial Times' FT 1000 list of Europe's fastest-growing companies for four consecutive years and won a Queen's Award for Innovation in 2019. KEY FEATURES: - Speech-to-text API in 55+ languages with accent-agnostic recognition - Real-time transcription with sub-second latency - Cloud, on-premise, and on-device deployment options - Flow API for building voice agent interactions - Medical model reducing errors on clinical terminology by up to 50%

Sovereignty